Advanced search
Publication Cover
Journal of Inflammation Research Volume 14, 2021 - Issue
Submit an article Journal homepage
106
Views
14
CrossRef citations to date
0
Altmetric
Review

Between Inflammation and Autophagy: The Role of Leptin-Adiponectin Axis in Cardiac Remodeling

Layla Kamareddine1 Department Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar;2 Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar;3 Biomedical Research Center, Qatar University, Doha, QatarView further author information
,
Crystal M Ghantous4 Department of Nursing and Health Sciences, Faculty of Nursing and Health Sciences, Notre Dame University-Louaize, Keserwan, LebanonView further author information
,
Soumaya Allouch5 Department of Basic Sciences, College of Medicine, QU Health, Qatar University, Doha, QatarView further author information
,
Sarah A Al-Ashmar2 Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar;5 Department of Basic Sciences, College of Medicine, QU Health, Qatar University, Doha, QatarView further author information
,
Gulsen Anlar2 Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar;5 Department of Basic Sciences, College of Medicine, QU Health, Qatar University, Doha, QatarView further author information
,
Surya Kannan2 Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar;5 Department of Basic Sciences, College of Medicine, QU Health, Qatar University, Doha, QatarORCID Iconhttps://orcid.org/0000-0001-9079-1325View further author information
ORCID Icon,
Laiche Djouhri2 Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar;5 Department of Basic Sciences, College of Medicine, QU Health, Qatar University, Doha, QatarORCID Iconhttps://orcid.org/0000-0001-8730-9470View further author information
ORCID Icon,
Hesham M Korashy2 Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar;6 Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, QatarORCID Iconhttps://orcid.org/0000-0002-5745-9643View further author information
ORCID Icon,
Abdelali Agouni2 Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar;6 Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, Doha, QatarORCID Iconhttps://orcid.org/0000-0002-8363-1582View further author information
ORCID Icon &
Asad Zeidan2 Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, Qatar;5 Department of Basic Sciences, College of Medicine, QU Health, Qatar University, Doha, QatarCorrespondence[email protected]
View further author information
 show all
Pages 5349-5365 | Published online: 16 Oct 2021

References

  • Ruan Y, Guo Y, Zheng Y, et al. Cardiovascular disease (CVD) and associated risk factors among older adults in six low-and middle-income countries: results from SAGE wave 1. BMC Public Health. 2018;18(1):778. doi:10.1186/s12889-018-5653-9
  • Kannan A, Janardhanan R. Hypertension as a risk factor for heart failure. Curr Hypertens Rep. 2014;16(7):447. doi:10.1007/s11906-014-0447-7
  • Wu J, Thabet SR, Kirabo A, et al. Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Circ Res. 2014;114(4):616–625. doi:10.1161/CIRCRESAHA.114.302157
  • Ghantous CM, Farhat R, Djouhri L, et al. Molecular mechanisms of adiponectin-induced attenuation of mechanical stretch-mediated vascular remodeling. Oxid Med Cell Longev. 2020;2020:6425782. doi:10.1155/2020/6425782
  • Lyon RC, Zanella F, Omens JH, Sheikh F. Mechanotransduction in cardiac hypertrophy and failure. Circ Res. 2015;116(8):1462–1476. doi:10.1161/CIRCRESAHA.116.304937
  • Maillet M, Van Berlo JH, Molkentin JD. Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol. 2013;14(1):38. doi:10.1038/nrm3495
  • Andrade-Oliveira V, Camara NO, Moraes-Vieira PM. Adipokines as drug targets in diabetes and underlying disturbances. J Diabetes Res. 2015;2015:681612. doi:10.1155/2015/681612
  • Park PH. Autophagy induction: a critical event for the modulation of cell death/survival and inflammatory responses by adipokines. Arch Pharm Res. 2018;41(11):1062–1073. doi:10.1007/s12272-018-1082-7
  • Nemchenko A, Chiong M, Turer A, Lavandero S, Hill JA. Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol. 2011;51(4):584–593. doi:10.1016/j.yjmcc.2011.06.010
  • Geng J, Baba M, Nair U, Klionsky DJ. Quantitative analysis of autophagy-related protein stoichiometry by fluorescence microscopy. J Cell Biol. 2008;182(1):129–140. doi:10.1083/jcb.200711112
  • Roever L, Palandri Chagas AC. Editorial: cardiac remodeling: new insights in physiological and pathological adaptations. Front Physiol. 2017;8:751. doi:10.3389/fphys.2017.00751
  • Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15(7):387–407.
  • Kehat I, Molkentin JD. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation. 2010;122(25):2727–2735. doi:10.1161/CIRCULATIONAHA.110.942268
  • Sayer G, Bhat G. The renin-angiotensin-aldosterone system and heart failure. Cardiol Clin. 2014;32(1):21–32. doi:10.1016/j.ccl.2013.09.002
  • Rababa’h AM, Guillory AN, Mustafa R, Hijjawi T. Oxidative stress and cardiac remodeling: an updated edge. Curr Cardiol Rev. 2018;14(1):53–59. doi:10.2174/1573403X14666180111145207
  • Wang C, Wang X. The interplay between autophagy and the ubiquitin-proteasome system in cardiac proteotoxicity. Biochim Biophys Acta. 2015;1852(2):188–194. doi:10.1016/j.bbadis.2014.07.028
  • Cao DJ, Gillette TG, Hill JA. Cardiomyocyte autophagy: remodeling, repairing, and reconstructing the heart. Curr Hypertens Rep. 2009;11(6):406–411. doi:10.1007/s11906-009-0070-1
  • Azevedo PS, Polegato BF, Minicucci MF, Paiva SAR, Zornoff LAM. Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq Bras Cardiol. 2016;106(1):62–69.
  • Leask A. Getting to the heart of the matter: new insights into cardiac fibrosis. Circ Res. 2015;116(7):1269–1276. doi:10.1161/CIRCRESAHA.116.305381
  • Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis. 2006;48(5):326–341. doi:10.1016/j.pcad.2006.02.001
  • Force T, Rosenzweig A, Choukroun G, Hajjar R. Calcineurin inhibitors and cardiac hypertrophy. Lancet. 1999;353(9161):1290–1292. doi:10.1016/S0140-6736(99)90016-8
  • Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res. 1998;39(1):89–105. doi:10.1016/S0008-6363(98)00076-5
  • Drazner MH. The transition from hypertrophy to failure: how certain are we? Am Heart Assoc. 2005;112:936-938. doi:10.1161/CIRCULATIONAHA.105.558734
  • Francis GS. Pathophysiology of chronic heart failure. Am J Med. 2001;110(7):37–46. doi:10.1016/S0002-9343(98)00385-4
  • Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016;118(11):1786–1807. doi:10.1161/CIRCRESAHA.115.306885
  • Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-Reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107(5):671–674. doi:10.1161/01.CIR.0000055188.83694.B3
  • Farkhondeh T, Llorens S, Pourbagher-Shahri AM, et al. An overview of the role of adipokines in cardiometabolic diseases. Molecules. 2020;25:21. doi:10.3390/molecules25215218
  • Mattu HS, Randeva HS. Role of adipokines in cardiovascular disease. J Endocrinol. 2013;216(1):T17–T36. doi:10.1530/JOE-12-0232
  • Vlasova M, Purhonen AK, Jarvelin MR, Rodilla E, Pascual J, Herzig KH. Role of adipokines in obesity-associated hypertension. Acta Physiologica. 2010;200(2):107–127. doi:10.1111/j.1748-1716.2010.02171.x
  • Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–432. doi:10.1038/372425a0
  • Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395(6704):763–770. doi:10.1038/27376
  • Ghantous CM, Kobeissy FH, Soudani N, et al. Mechanical stretch-induced vascular hypertrophy occurs through modulation of leptin synthesis-mediated ROS formation and GATA-4 nuclear translocation. Front Pharmacol. 2015;6:240.
  • Soudani N, Ghantous CM, Farhat Z, Shebaby WN, Zibara K, Zeidan A. Calcineurin/NFAT activation-dependence of leptin synthesis and vascular growth in response to mechanical stretch. Front Physiol. 2016;7:433. doi:10.3389/fphys.2016.00433
  • Landecho MF, Tuero C, Valenti V, Bilbao I, de la Higuera M, Fruhbeck G. Relevance of leptin and other adipokines in obesity-associated cardiovascular risk. Nutrients. 2019;11:11. doi:10.3390/nu11112664
  • Yadav A, Kataria MA, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. 2013;417:80–84. doi:10.1016/j.cca.2012.12.007
  • Fernández-Riejos P, Najib S, Santos-Alvarez J, et al. Role of leptin in the activation of immune cells. Mediators Inflamm. 2010;2010:568343. doi:10.1155/2010/568343
  • Cava AL, Matarese G. The weight of leptin in immunity. Nat Rev Immunol. 2004;4(5):371–379. doi:10.1038/nri1350
  • Paz-Filho G, Mastronardi C, Franco CB, Wang KB, Wong ML, Licinio J. Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications. Arq Bras Endocrinol Metabol. 2012;56(9):597–607. doi:10.1590/S0004-27302012000900001
  • Chandra RK. Cell-mediated immunity in genetically obese (C57BL/6J ob/ob) mice. Am J Clin Nutr. 1980;33(1):13–16. doi:10.1093/ajcn/33.1.13
  • Mandel MA, Mahmoud AAF. Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J Immunol. 1978;120(4):1375.
  • McLaughlin T, Ackerman SE, Shen L, Engleman E. Role of innate and adaptive immunity in obesity-associated metabolic disease. J Clin Invest. 2017;127(1):5–13. doi:10.1172/JCI88876
  • Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflammation. 2013;2013:139239. doi:10.1155/2013/139239
  • Iikuni N, Lam QLK, Lu L, Matarese G, La Cava A. Leptin and inflammation. Curr Immunol Rev. 2008;4(2):70–79. doi:10.2174/157339508784325046
  • Francisco V, Pino J, Campos-Cabaleiro V, et al. Obesity, fat mass and immune system: role for leptin. Front Physiol. 2018;9:640. doi:10.3389/fphys.2018.00640
  • Zarkesh-Esfahani H, Pockley AG, Wu Z, Hellewell PG, Weetman AP, Ross RJ. Leptin indirectly activates human neutrophils via induction of TNF-alpha. J Immunol. 2004;172(3):1809–1814. doi:10.4049/jimmunol.172.3.1809
  • Poetsch MS, Strano A, Guan K. Role of leptin in cardiovascular diseases. Front Endocrinol (Lausanne). 2020;11:354. doi:10.3389/fendo.2020.00354
  • Agrawal S, Gollapudi S, Su H, Gupta S. Leptin activates human B cells to secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J Clin Immunol. 2011;31(3):472–478. doi:10.1007/s10875-010-9507-1
  • Barouch LA, Berkowitz DE, Harrison RW, O’Donnell CP, Hare JM. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation. 2003;108(6):754–759. doi:10.1161/01.CIR.0000083716.82622.FD
  • Tune JD, Considine RV. Effects of leptin on cardiovascular physiology. J Am Soc Hypertens. 2007;1(4):231–241. doi:10.1016/j.jash.2007.04.001
  • Hall ME, Harmancey R, Stec DE. Lean heart: role of leptin in cardiac hypertrophy and metabolism. World J Cardiol. 2015;7(9):511–524. doi:10.4330/wjc.v7.i9.511
  • Rajapurohitam V, Gan XT, Kirshenbaum LA, Karmazyn M. The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res. 2003;93(4):277–279. doi:10.1161/01.RES.0000089255.37804.72
  • Chaban R, Buschmann K, Ghazy A, et al. In vitro effect of leptin on human cardiac contractility. J Nutr Sci. 2019;8:e12–e12. doi:10.1017/jns.2019.6
  • Dong F, Zhang X, Ren J. Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor–NADPH oxidase pathway. Hypertension. 2006;47(2):222–229. doi:10.1161/01.HYP.0000198555.51645.f1
  • Nickola MW, Wold LE, Colligan PB, Wang G-J, Samson WK, Ren J. Leptin attenuates cardiac contraction in rat ventricular myocytes. Hypertension. 2000;36(4):501–505. doi:10.1161/01.HYP.36.4.501
  • Luo L-J, Liu Y-P, Yuan X, et al. Leptin attenuates the contractile function of adult rat cardiomyocytes involved in oxidative stress and autophagy. Acta Cardiologica Sinica. 2016;32(6):723–730.
  • Barouch L, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi A. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. nature. 2002;416(6878):337–339. doi:10.1038/416337a
  • Carter S, Caron A, Richard D, Picard F. Role of leptin resistance in the development of obesity in older patients. Clin Interv Aging. 2013;8:829–844.
  • Illiano G, Naviglio S, Pagano M, et al. Leptin affects adenylate cyclase activity in H9c2 cardiac cell line: effects of short- and long-term exposure. Am J Hypertens. 2002;15(7 Pt 1):638–643. doi:10.1016/S0895-7061(02)02925-4
  • Ma Y, Li J. Metabolic shifts during aging and pathology. Compr Physiol. 2015;5(2):667–686.
  • Atkinson LL, Fischer MA, Lopaschuk GD. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J Biol Chem. 2002;277(33):29424–29430. doi:10.1074/jbc.M203813200
  • Nakata N, Soejima N, Maruyama I. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes. 1999;48:426–429. doi:10.2337/diabetes.48.2.426
  • Zeidan A, Rajapurohitam V, Javadov S, Chakrabarti S, Karmazyn M. Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1-dependent mechanisms and mediates stretch-induced hypertrophy. J Pharmacol Exp Thera. 2005;315:1075–1084. doi:10.1124/jpet.105.091561
  • Ferrao RD, Wallweber HJ, Lupardus PJ. Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation. Elife. 2018;7:e38089. doi:10.7554/eLife.38089
  • Procaccini C, Lourenco EV, Matarese G, La Cava A. Leptin signaling: a key pathway in immune responses. Curr Signal Transduct Ther. 2009;4(1):22–30. doi:10.2174/157436209787048711
  • Sobrino Crespo C, Perianes Cachero A, Puebla Jiménez L, Barrios V, Arilla Ferreiro E. Peptides and food intake. Front Endocrinol (Lausanne). 2014;5:58. doi:10.3389/fendo.2014.00058
  • Chong ZZ, Maiese K. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol. 2007;22(11):1251–1267.
  • Thon M, Hosoi T, Ozawa K. Possible integrative actions of leptin and insulin signaling in the hypothalamus targeting energy homeostasis. Front Endocrinol (Lausanne). 2016;7:138. doi:10.3389/fendo.2016.00138
  • Tsou RC, Bence KK. Central regulation of metabolism by protein tyrosine phosphatases. Front Neurosci. 2013;6:192. doi:10.3389/fnins.2012.00192
  • Mullen M, Gonzalez-Perez RR. Leptin-induced JAK/STAT signaling and cancer growth. Vaccines (Basel). 2016;4(3):26. doi:10.3390/vaccines4030026
  • Buettner C, Pocai A, Muse ED, Etgen AM, Myers MG Jr, Rossetti L. Critical role of STAT3 in leptin’s metabolic actions. Cell Metab. 2006;4(1):49–60. doi:10.1016/j.cmet.2006.04.014
  • Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ Res. 2007;101(6):545–559. doi:10.1161/CIRCRESAHA.107.156596
  • Zeidan A, Javadov S, Karmazyn M. Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes. Cardiovasc Res. 2006;72(1):101–111.
  • Zeidan A, Javadov S, Chakrabarti S, Karmazyn M. Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei. Cardiovasc Res. 2007;77(1):64–72. doi:10.1093/cvr/cvm020
  • Hoffman L, Jensen CC, Yoshigi M, Beckerle M. Mechanical signals activate p38 MAPK pathway-dependent reinforcement of actin via mechanosensitive HspB1. Mol Biol Cell. 2017;28(20):2661–2675. doi:10.1091/mbc.e17-02-0087
  • Fearnley CJ, Roderick HL, Bootman MD. Calcium signaling in cardiac myocytes. Cold Spring Harb Perspect Biol. 2011;3(11):a004242–a004242. doi:10.1101/cshperspect.a004242
  • Sadoshima J, Izumo S. Signal transduction pathways of angiotensin II–induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res. 1993;73(3):424–438. doi:10.1161/01.RES.73.3.424
  • Zou Y, Komuro I, Yamazaki T, et al. Protein kinase C, but not tyrosine kinases or Ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes. J Biol Chem. 1996;271(52):33592–33597. doi:10.1074/jbc.271.52.33592
  • Thorburn A, Thorburn J, Chen S-Y, et al. HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem. 1993;268(3):2244–2249. doi:10.1016/S0021-9258(18)53988-0
  • Kudryavtseva O, Aalkjaer C, Matchkov VV. Vascular smooth muscle cell phenotype is defined by Ca2+-dependent transcription factors. Febs J. 2013;280(21):5488–5499. doi:10.1111/febs.12414
  • Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol. 1997;15:707–747. doi:10.1146/annurev.immunol.15.1.707
  • Liu Q, Chen Y, Auger-Messier M, Molkentin JD. Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ Res. 2012;110(8):1077–1086. doi:10.1161/CIRCRESAHA.111.260729
  • Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science. 1997;275(5308):1930–1933. doi:10.1126/science.275.5308.1930
  • Saito T, Fukuzawa J, Osaki J, et al. Roles of calcineurin and calcium/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy. J Mol Cell Cardiol. 2003;35(9):1153–1160. doi:10.1016/S0022-2828(03)00234-7
  • Liang Q, Molkentin JD. Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J Mol Cell Cardiol. 2003;35(12):1385–1394. doi:10.1016/j.yjmcc.2003.10.001
  • Molkentin JD, Lu J-R, Antos CL, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93(2):215–228. doi:10.1016/S0092-8674(00)81573-1
  • Zhu J, McKeon F. NF-AT activation requires suppression of Crm1-dependent export by calcineurin. Nature. 1999;398(6724):256. doi:10.1038/18473
  • Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003;17(18):2205–2232. doi:10.1101/gad.1102703
  • Goldspink PH, McKinney RD, Kimball VA, Geenen DL, Buttrick PM. Angiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporin A in adult rats. Mol Cell Biochem. 2001;226(1–2):83–88. doi:10.1023/A:1012789819926
  • Shimoyama M, Hayashi D, Zou Y, et al. Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension. Circulation. 2000;102(16):1996–2004. doi:10.1161/01.CIR.102.16.1996
  • Sussman MA, Lim HW, Gude N, et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 1998;281(5383):1690–1693. doi:10.1126/science.281.5383.1690
  • Meguro T, Hong C, Asai K, et al. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ Res. 1999;84(6):735–740. doi:10.1161/01.RES.84.6.735
  • Mende U, Kagen A, Cohen A, Aramburu J, Schoen F, Neer E. Transient cardiac expression of constitutively active Gαq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci. 1998;95(23):13893–13898. doi:10.1073/pnas.95.23.13893
  • Luo Z, Shyu K-G, Gualberto A, Walsh K. Calcineurin inhibitors and cardiac hypertrophy. Nat Med. 1998;4(10):1092. doi:10.1038/2578
  • Zhang W, Kowal RC, Rusnak F, Sikkink RA, Olson EN, Victor RG. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res. 1999;84(6):722–728. doi:10.1161/01.RES.84.6.722
  • Fatkin D, McConnell BK, Mudd JO, et al. An abnormal Ca 2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy. J Clin Invest. 2000;106(11):1351–1359. doi:10.1172/JCI11093
  • Janssen PM, Zeitz O, Keweloh B, et al. Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium. Cardiovasc Res. 2000;47(1):99–107. doi:10.1016/S0008-6363(00)00052-3
  • Park KS, Kim TK, Kim DH. Cyclosporin A treatment alters characteristics of Ca2+-release channel in cardiac sarcoplasmic reticulum. Am J Physiol-Heart Circulatory Physiol. 1999;276(3):H865–H872. doi:10.1152/ajpheart.1999.276.3.H865
  • Klee CB, Ren H, Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem. 1998;273(22):13367–13370. doi:10.1074/jbc.273.22.13367
  • Kilić A, Rajapurohitam V, Sandberg SM, et al. A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1–calcineurin pathway. Cardiovasc Res. 2010;88(3):434–442. doi:10.1093/cvr/cvq254
  • Taigen T, De Windt LJ, Lim HW, Molkentin JD. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A. 2000;97(3):1196–1201. doi:10.1073/pnas.97.3.1196
  • Zou Y, Yao A, Zhu W, et al. Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin. Circulation. 2001;104(1):102–108. doi:10.1161/hc2601.090987
  • Bueno OF, Brandt EB, Rothenberg ME, Molkentin JD. Defective T cell development and function in calcineurin A beta -deficient mice. Proc Natl Acad Sci USA. 2002;99(14):9398–9403. doi:10.1073/pnas.152665399
  • Wilkins BJ, Molkentin JD. Calcineurin and cardiac hypertrophy: where have we been? Where are we going? J Physiol. 2002;541(Pt 1):1–8. doi:10.1113/jphysiol.2002.017129
  • Gu HF. Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms. Biomark Insights. 2009;4:123–133. doi:10.4137/BMI.S3453
  • Ghoshal K, Bhattacharyya M. Adiponectin: probe of the molecular paradigm associating diabetes and obesity. World J Diabetes. 2015;6(1):151–166. doi:10.4239/wjd.v6.i1.151
  • Berk ES, Kovera AJ, Boozer CN, Pi-Sunyer FX, Johnson JA, Albu JB. Adiponectin levels during low- and high-fat eucaloric diets in lean and obese women. Obes Res. 2005;13(9):1566–1571. doi:10.1038/oby.2005.192
  • Anders H, Berg T. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13:84–89.
  • Ghantous CM, Azrak Z, Hanache S, Abou-Kheir W, Zeidan A. Differential role of leptin and adiponectin in cardiovascular system. Int J Endocrinol. 2015;2015:534320. doi:10.1155/2015/534320
  • Yamauchi T, Kadowaki T. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab. 2013;17(2):185–196. doi:10.1016/j.cmet.2013.01.001
  • Parker-Duffen JL, Nakamura K, Silver M, et al. Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo. J Biol Chem. 2014;289(23):16200–16213. doi:10.1074/jbc.M114.548115
  • Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116(7):1784–1792. doi:10.1172/JCI29126
  • Resinka TJ, M P, Joshia MB, Kyriakakisa E, Erneb P. Cadherins in cardiovascular disease. J Swiss Soc Infect Dis. 2009;139:0930.
  • Amirzadegan A, Shakarami A, Borumand MA, Davoodi G, Ghaffari-Marandi N, Jalali A. Correlation between plasma adiponectin levels and the presence and severity of coronary artery disease. J Tehran Heart Cent. 2013;8(3):140–145.
  • Kim-Mitsuyama S, Soejima H, Yasuda O, et al. Total adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trial. Sci Rep. 2019;9(1):16589. doi:10.1038/s41598-019-52977-x
  • Hopkins TA, Ouchi N, Shibata R, Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc Res. 2007;74(1):11–18. doi:10.1016/j.cardiores.2006.10.009
  • Teresa A, Hopkins NO, Shibata R, Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc Res. 2007;74:11–18.
  • Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, Fallah P, Bazi Z. Adiponectin as a potential biomarker of vascular disease. Vasc Health Risk Manag. 2015;11:55–70.
  • Zhang M, Dong Y, Xu J, et al. Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide. Circ Res. 2008;102(3):328–337. doi:10.1161/CIRCRESAHA.107.163253
  • Nour-Eldine W, Ghantous CM, Zibara K, et al. Adiponectin attenuates angiotensin II-induced vascular smooth muscle cell remodeling through nitric oxide and the RhoA/ROCK pathway. Front Pharmacol. 2016;7:86. doi:10.3389/fphar.2016.00086
  • Li L, Xu J, He L, et al. The role of autophagy in cardiac hypertrophy. Acta Biochim Biophys Sin (Shanghai). 2016;48(6):491–500. doi:10.1093/abbs/gmw025
  • Ucar A, Gupta SK, Fiedler J, et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun. 2012;3(1):1078. doi:10.1038/ncomms2090
  • Pyo J-O, Yoo S-M, Ahn -H-H, et al. Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat Commun. 2013;4:2300. doi:10.1038/ncomms3300
  • Yoshii SR, Kuma A, Mizushima N. Transgenic rescue of Atg5-null mice from neonatal lethality with neuron-specific expression of ATG5: systemic analysis of adult Atg5-deficient mice. Autophagy. 2017;13(4):763–764. doi:10.1080/15548627.2017.1280221
  • Khandia R, Dadar M, Munjal A, et al. A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: current knowledge and prospects for disease prevention, novel drug design, and therapy. Cells. 2019;8(7):674. doi:10.3390/cells8070674
  • Randow F, Münz C. Autophagy in the regulation of pathogen replication and adaptive immunity. Trends Immunol. 2012;33(10):475–487. doi:10.1016/j.it.2012.06.003
  • Li WW, Li J, Bao JK. Microautophagy: lesser-known self-eating. Cell Mol Life Sci. 2012;69(7):1125–1136. doi:10.1007/s00018-011-0865-5
  • Cuervo AM, Wong E. Chaperone-mediated autophagy: roles in disease and aging. Cell Res. 2014;24(1):92–104. doi:10.1038/cr.2013.153
  • Rifki OF, Hill JA. Cardiac autophagy: good with the bad. J Cardiovasc Pharmacol. 2012;60(3):248–252. doi:10.1097/FJC.0b013e3182646cb1
  • Miyamoto S. Autophagy and cardiac aging. Cell Death Differ. 2019;26(4):653–664. doi:10.1038/s41418-019-0286-9
  • Nishida K, Otsu K. Autophagy during cardiac remodeling. J Mol Cell Cardiol. 2016;95:11–18. doi:10.1016/j.yjmcc.2015.12.003
  • Yamaguchi O, Higuchi Y, Hirotani S, et al. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc Natl Acad Sci. 2003;100(26):15883. doi:10.1073/pnas.2136717100
  • Dammrich J, Pfeifer U. Cardiac hypertrophy in rats after supravalvular aortic constriction. II. Inhibition of cellular autophagy in hypertrophying cardiomyocytes. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983;43(3):287–307. doi:10.1007/BF02932962
  • Osterholt M, Nguyen TD, Schwarzer M, Doenst T. Alterations in mitochondrial function in cardiac hypertrophy and heart failure. Heart Fail Rev. 2013;18(5):645–656. doi:10.1007/s10741-012-9346-7
  • Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol Cell. 2010;40(2):280–293. doi:10.1016/j.molcel.2010.09.023
  • Alers S, Löffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol. 2012;32(1):2–11. doi:10.1128/MCB.06159-11
  • Chiu B, Jantuan E, Shen F, Chiu B, Sergi C. Autophagy-inflammasome interplay in heart failure: a systematic review on basics, pathways, and therapeutic perspectives. Ann Clin Lab Sci. 2017;47(3):243–252.
  • Miyata S, Takemura G, Kawase Y, et al. Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am J Pathol. 2006;168(2):386–397. doi:10.2353/ajpath.2006.050137
  • Qian M, Fang X, Wang X. Autophagy and inflammation. Clin Transl Med. 2017;6(1):24. doi:10.1186/s40169-017-0154-5
  • Maphasa RE, Meyer M, Dube A. The macrophage response to mycobacterium tuberculosis and opportunities for autophagy inducing nanomedicines for tuberculosis therapy. Front Cell Infect Microbiol. 2021;10:915. doi:10.3389/fcimb.2020.618414
  • Yuan Y, Ding D, Zhang N, et al. TNF-α induces autophagy through ERK1/2 pathway to regulate apoptosis in neonatal necrotizing enterocolitis model cells IEC-6. Cell Cycle. 2018;17(11):1390–1402. doi:10.1080/15384101.2018.1482150
  • Djavaheri-Mergny M, Amelotti M, Mathieu J, Besançon F, Bauvy C, Codogno P. Regulation of autophagy by NF-kappaB transcription factor and reactives oxygen species. Autophagy. 2007;3(4):390–392. doi:10.4161/auto.4248
  • Ding Y, Choi ME. Regulation of autophagy by TGF-β: emerging role in kidney fibrosis. Semin Nephrol. 2014;34(1):62–71. doi:10.1016/j.semnephrol.2013.11.009
  • Khan NM, Ansari MY, Haqqi TM. Sucrose, but not glucose, blocks IL1-β-induced inflammatory response in human chondrocytes by inducing autophagy via AKT/mTOR pathway. J Cell Biochem. 2017;118(3):629–639. doi:10.1002/jcb.25750
  • Liu ZQ, Zhao S, Fu WQ. Insulin-like growth factor 1 antagonizes lumbar disc degeneration through enhanced autophagy. Am J Transl Res. 2016;8(10):4346–4353.
  • Wang X, Qi H, Wang Q, et al. FGFR3/fibroblast growth factor receptor 3 inhibits autophagy through decreasing the ATG12-ATG5 conjugate, leading to the delay of cartilage development in achondroplasia. Autophagy. 2015;11(11):1998–2013. doi:10.1080/15548627.2015.1091551
  • Park HJ, Lee SJ, Kim SH, et al. IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway. Mol Immunol. 2011;48(4):720–727. doi:10.1016/j.molimm.2010.10.020
  • Malik SA, Mariño G, BenYounes A, et al. Neuroendocrine regulation of autophagy by leptin. Cell Cycle. 2011;10(17):2917–2923.
  • Ravikumar B, Sarkar S, Davies JE, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 2010;90(4):1383–1435. doi:10.1152/physrev.00030.2009
  • Gogiraju R, Hubert A, Fahrer J, et al. Endothelial leptin receptor deletion promotes cardiac autophagy and angiogenesis following pressure overload by suppressing akt/mtor signaling. Circ Heart Fail. 2019;12(1):e005622.
  • Machender RK, Nathan D. Autophagy inhibition rescues against leptin-induced cardiac contractile dysfunction. Curr Pharm Des. 2014;20(4):675–683. doi:10.2174/13816128113199990019
  • Nepal S, Kim MJ, Hong JT, et al. Autophagy induction by leptin contributes to suppression of apoptosis in cancer cells and xenograft model: involvement of p53/FoxO3A axis. Oncotarget. 2015;6(9):7166–7181. doi:10.18632/oncotarget.3347
  • Essick EE, Wilson RM, Pimentel DR, et al. Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes. PLoS One. 2013;8(7):e68697. doi:10.1371/journal.pone.0068697
  • Guo R, Zhang Y, Turdi S, Ren J. Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy. Biochim Biophys Acta. 2013;1832(8):1136–1148. doi:10.1016/j.bbadis.2013.03.013
  • Qi G-M, Jia L-X, Li Y-L, Li -H-H, Du J. Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy. Endocrinology. 2014;155(6):2254–2265. doi:10.1210/en.2013-2011
  • Jahng JW, Turdi S, Kovacevic V, Dadson K, Li RK, Sweeney G. Pressure overload-induced cardiac dysfunction in aged male adiponectin knockout mice is associated with autophagy deficiency. Endocrinology. 2015;156(7):2667–2677. doi:10.1210/en.2015-1162

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.